FDA approves Zevaskyn as the first cell-based gene therapy for RDEB wounds after strong results in pivotal and long-term studies.
Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy
Where Today's News Shapes Tomorrow
February 15, 2026
Headlines
